CURRENT SHAREHOLDERS: Zamansky LLC Investigates AmerisourceBergen (ABC) for Potential Breaches of Fiduciary Duties
Zamansky LLC announces that it is investigating AmerisourceBergen Corporation (NYSE:ABC) (“AmerisourceBergen” or the “Company”)
for potential breaches of fiduciary duties by its senior officers and board of directors. If you are a shareholder of
AmerisourceBergen who still holds your shares, please contact our firm for information.
On October 1, 2018, the Company announced that it will pay $625 million to resolve civil fraud charges over its sales of
refilled syringes to cancer patients, double-billing and providing kick-backs to doctors. The Company previously settled criminal
charges, paying $260 million in fines. The Company’s former Chief Operating Officer stands to receive a portion of a whistleblower
payment, according to public reports.
According to Jake Zamansky, investment fraud attorney, these settlements and whistleblower allegations raise concerns that the
Company’s officers and directors breached their fiduciary duties owed to the Company and its shareholders. The law firm is
investigating a potential shareholder derivative action.
What AmerisourceBergen Shareholders Can Do
If you are a current long-term shareholder of AmerisourceBergen who still holds your stock, please contact us to review or
discuss your legal rights. You may, without obligation or cost to you, email jake@zamansky.com or call the law firm at (212) 742-1414.
About Zamansky LLC
Zamansky LLC is a leading investment fraud law firm with experience handling securities, hedge fund, ERISA and other shareholder
class action and derivative litigation. We are investment fraud attorneys who represent both individual and institutional
investors. Our practice is nationally recognized for our ability to aggressively prosecute cases and recover investment losses.
To learn more about Zamansky LLC, please visit our website,
http://www.zamansky.com.
Zamansky LLC
Jake Zamansky, 212-742-1414
jake@zamansky.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20181026005528/en/